Good afternoon, everyone, and thank you for participating in today's conference call to discuss Nature's Sunshine's financial results for the third quarter ended September 30, 2022. Joining us today are Nature's Sunshine CEO, Terrence Moorehead, Executive Vice President of Global Supply Chain, Martin Gonzalez, Interim CFO, Jonathan LaNoy, and General Counsel, Nate Brower. Following their remarks, we'll open the call for your questions. Before we go further, I would like to turn the call over to Mr. Brower as he reads the company's Safe Harbor statement within the meaning of the Private Securities Litigation Reform Act of 1995 that provides important cautions regarding forward-looking statements. Nate, please go ahead. Yeah. Thank you, Sarah. Good afternoon, and thanks for joining our conference call to discuss our third quarter 2022 financial results. I'd like to remind everyone that this call is available for replay via telephonic dial-in through November 17th and via a live webcast that will be posted in the investor relations portion of our website at ir.naturessunshine.com. The information on this call contains forward-looking statements. Those are statements often characterized by terminology such as believe, hope, may, anticipate, expect, and other similar expressions. Forward-looking statements are not guarantees of future performance, and the actual results may be materially different from the results implied by forward-looking statements. Factors that could cause results to differ materially from those implied herein include but are not limited to those factors disclosed in the company's annual report on Form 10-K under the caption Risk Factors and other reports filed with the Securities and Exchange Commission. The information on this call speaks only as of today's date, and the company disclaims any duty to update the information provided herein. Now, I would like to turn this call over to the CEO of Nature's Sunshine, Terrence Moorehead. Terrence. Thank you, Nate, and good afternoon, everyone. I wanna thank you for joining today's call to review our third quarter results. The resilience of our portfolio was on display in the third quarter, where despite unprecedented external headwinds, we delivered third-quarter sales of $105 million on a reported basis or $112 million when removing the impact of foreign exchange. To put these results in perspective, our third-quarter sales were only down 2% versus prior year on a constant dollar basis, and year to date sales were actually up 3% in local currency. Both measures reflect the underlying strength of our business, especially given the current environment where it has become more difficult to drive customer engagement. What's more, due to inflationary pressures and volatile foreign exchange rates, everything has become more expensive. As a result, third-quarter gross margins contracted as inflation and foreign exchange negatively impacted cost of goods by approximately $3 million or roughly 300 basis points versus Q3 of the prior year. Sales declines driven by foreign exchange also negatively impacted profitability by an additional $3 million, which contributed to Adjusted EBITDA of $6.8 million for the third quarter versus $12.9 million in Q3 of the prior year. As I shared last quarter, we are committed to meeting these challenges head on and now have a detailed plan to deliver $10-$12 million of gross savings to help improve profitability. I've invited our new supply chain lead, Martin Gonzalez, to join us today, so he can briefly walk you through our plans. First, I wanna share a few more comments about the quarter to help provide some perspective. Despite the challenges from the external headwinds, we continue to gain traction from three key strategic investments. First, our investment in field activation continues to gain traction in markets like Taiwan, Japan, and South Korea, where sales increased 97%, 22%, and 8%, respectively, on a local currency basis. While we believe the underlying fundamentals of our business in China remain strong, sales struggled in the third quarter, down 31%, driven by deteriorating macroeconomic conditions and the hangover effects from China's Zero-COVID policy. Once external headwinds abate, we hope to see a return to growth. Overall, Asia-Pacific led the company's third-quarter results, delivering 12% sales growth in local currency and 21% sales growth year to date. Second, our investment in digital activation continues to gain traction in North America as digital sales increased 22% in the third quarter. We've continued to invest in digital, and as a result, we've been able to attract new customers, double the effectiveness of our CRM campaigns, and our Subscribe & Thrive autoship program now represents about 27% of sales. Solid gains from digital were more than offset by average order declines from existing customers who continue to order Nature's Sunshine products but are purchasing about one less unit per order on average. This is consistent with the broader market trend, where we see consumers offsetting inflationary pressures by purchasing smaller quantities, delaying purchases, or trading down to cheaper brands. Overall, North America sales were down 16% in the third quarter. Finally, our investment in customer growth has helped us gain some early traction in both Central and Eastern Europe and Latin America. In Central and Eastern Europe, initiatives in Poland, Turkey, and several Baltic states helped partially offset the gap created by the war in Ukraine. We're still preparing for the relaunch of the business in Western Europe, where economic challenges have customers buying and spending less, negatively impacting orders and average order size. Overall, Europe's third quarter sales were better than expected as we grew 13% on a sequential basis versus the second quarter, and we're only down 6% versus prior year in constant dollars. This is a tremendous result and speaks to the skill, determination, and resilience of our regional leadership teams. In Latin America, customer growth initiatives helped attract more new customers in the last two months of the third quarter than in the first and second quarters combined. The positive momentum was offset by a decrease in orders from existing customers impacted by the depressed economy. LatAm third quarter sales were down 14% in local currency. We're still on the front end of our transformation and are pleased with the progress our new leadership team has made, recruiting new talent and creating a roadmap for the future. Importantly, we're not sitting idly waiting for the effects of the global headwinds to pass. We're fighting back by continuing to invest in our growth strategies and by launching a comprehensive initiative to optimize gross margins and reduce SG&A. As I mentioned earlier, we've identified a series of initiatives to drive out costs and improve productivity over the next 18 months. With that in mind, I'd like to invite our new head of supply chain, Martin Gonzalez, to update you on our plans related to gross margin. Martin. Good afternoon, everyone. It's good to be here with all of you. As you may know, I joined Nature's Sunshine a little over five months ago as the Executive Vice President for Global Supply Chain. Since joining the company, I've been working in partnership with our finance, sales, marketing, R&D, and supply chain team to identify opportunities to optimize our gross margins and offset increased costs driven by inflation. Working together over the past few months, the team has identified three key initiatives that will deliver significant savings and will allow us to make meaningful progress against our gross margin targets. The initiatives will be launched over the next 12-18 months and will deliver approximately $10 million of gross savings. I would like to briefly give you a sense of the initiatives we're working on. Our first initiative involves a deep dive review of our ingredients, packaging, and formulations. Raw materials represent a significant portion of our cost of goods, so they are an important area to explore. We believe there are significant savings from optimizing the materials using our products, and we are aggressively looking for opportunities to drive out cost while maintaining quality and performance. Using one of our top products as an example, we found that by optimizing the ingredients, we could improve the flavor, reduce sugar, improve the fiber content, and increase the gross margin profile by half a million dollars per year. That's just one example, but there are many products in our portfolio that will help us to deliver the efficiencies we are looking to achieve. Our second initiative focuses on improving efficiencies and driving waste out of our manufacturing processes. Our small batch manufacturing capabilities give us real advantage when it comes to product quality and performance, but they can also add complexity to the process when run times are negatively impacted by unnecessary changeovers. For the past few months, we have been analyzing how we can more effectively optimize our production schedules by prioritizing production runs, improving preventive maintenance, and reducing changeover time. This initiative will allow us to increase uptime, improve yield, and deliver significant savings. Our third initiative focuses on logistics and transportation, where we are working to improve truck utilization, increase pallet density in the warehouse, and reduce the amount of air freight. We believe this offers significant potential to drive savings. Again, we expect these initiatives to improve our gross profit by approximately $10 million or 200-250 basis points of gross margin. Now I will turn the call back over to Terrence. Terrence. Thank you, Martin. While we expect these savings to start impacting results in late 2023 to 2024, the project teams are already up and running and making progress. This initiative is an important part of a comprehensive approach to improve gross margin, and we're committed to delivering the initiatives that Martin outlined. I wanna reiterate our steadfast commitment to successfully navigating this unique period of market volatility and uncertainty, and I wanna leave you with three key takeaways. First, the persistent challenges posed by inflation, foreign exchange, and COVID related disruptions were the primary factors negatively impacting our performance. Second, despite the challenging environment, Nature's Sunshine continues to be healthy and the underlying fundamentals of the business are sound. We have a strong balance sheet, customer orders are still largely holding, and when we adjust for currency, performance is still near historical highs. Third, we continue to see positive results from our targeted investments that we've made. We're gonna lean into the investments we believe will drive growth going forward. Finally, we're fighting back against the challenges of the current macroeconomic landscape by introducing a comprehensive initiative that will deliver gross savings of $10 million-$12 million from the gross margin initiatives Martin reviewed and SG&A reductions from across the business. In challenging times like these, it's more important than ever to stay focused and drive our strategies forward, and that's exactly what we're going to do. Backed by our strong balance sheet and our team of experts around the globe, we remain confident in our ability to provide long-term value to our stakeholders. Before passing the call over to John, I'd like to recognize our outgoing CFO, Joe Baty. On behalf of the board and all of our employees here at Nature's Sunshine, I wanna thank Joe for his valuable contributions. Joe played a key role in developing a strong finance team and driving improvements that have put Nature's Sunshine in a position to win. I'm deeply appreciative of Joe's service and leadership and wish him all the best. With that, I'd like to turn the call over to John LaNoy, our interim CFO, who will walk you through our financials in more detail. Jon? Thank you, Terrence, and good afternoon, everyone. Net sales in the third quarter were $104.5 million, compared to $114.7 million a year ago. This 9% decline was largely driven by declines in North America and Europe. As Terrence mentioned, excluding the impact from foreign exchange rates, consolidated constant currency net sales decreased only 2% in the third quarter. Gross margin in the third quarter was 71.6%, compared to 74.4% a year ago. The decline was primarily driven by inflationary pressures on our cost of goods sold related to increases in materials, production and transportation costs, as well as the adverse movements in foreign exchange rates. Third quarter volume incentives as a percentage of net sales were 31.6%, compared to 31.2% in the prior year quarter. The slight increase was due to changes in market mix. Selling, general, and administrative expenses during the third quarter were reduced to $36.8 million, compared to $39.5 million a year ago. The reduction was from lower service fees in China and lower overall compensation costs, partially offset by increases from a return to in-person events, promotion related activities, and investments in our digital initiatives. As a percentage of net sales, SG&A expenses were 35.2% for the third quarter of 2022, compared to 34.4% a year ago. Reflective of gross margin pressures, operating income was $5 million or 4.8% of net sales, compared to $10 million or 8.7% of net sales in the prior year. GAAP net income attributable to common shareholders for the third quarter was $0.1 million or breakeven per diluted share as compared to $4.9 million or $0.24 per diluted share a year ago. In addition to reduced operating margins, the decline also reflects increases of $1.1 million in valuation allowances against deferred tax assets for which we do not expect to receive a benefit. Excluding these allowances, our tax rate would have been 52.7% for the third quarter. Adjusted EBITDA, as defined in our press release, was $6.8 million compared to $12.9 million in the third quarter of 2021. Moving on to liquidity and our capital allocation plan. Our balance sheet remains clean with cash and cash equivalents of $57 million and only $1.5 million of debt. During the quarter, inventory decreased approximately $3 million versus the second quarter, and we believe aggregate inventories will continue to decline in the fourth quarter as we work to right-size the amount of inventory within our supply chain. As part of our capital allocation plan, we continue to utilize our share repurchase authorization, buying 93,000 shares in the third quarter for $1 million or an average of $10.48 per share. At September 30 of this year, 24.6 million remains of our 30 million share repurchase program. Looking beyond share repurchases, our healthy capital allocation structure positions us well to continue our digital transformation, supply chain, and other strategic investments. Now turning to our outlook, which includes the assumption that the ongoing market headwinds will persist. We continue to expect top line sales for 2022 to reflect a low- to mid-single-digit decline versus 2021. As previously communicated, we expect overall European sales for 2022 to decline approximately 15%-25% as compared to 2021, and continued declines in North America given the current inflationary environment. Lastly, we expect Asia to increase in the mid-single digits as compared to 2021, with the current growth in Japan, Korea, and Taiwan offset by declines in China due to the current COVID restrictions. The challenges presented by inflation and foreign currency volatility are expected to persist. As a result, we expect to have continued pressures on our gross margins. While Martin has shared several initiatives we are actively pursuing to improve gross margins, I would remind you that the impact of these actions will not be reflected in our results until late 2023 and into 2024 as these changes cycle through our inventory. Due to our strong belief in the long-term potential and success of Nature's Sunshine, our investment in growth-directed initiatives will continue. As a result, while we work to optimize our SG&A spend to support our investments, we expect SG&A as a percentage of net sales to continue to increase. We currently expect our Adjusted EBITDA margin, including the add back for certain war-related working capital charges, may decline three to five full percentage points from the 11% we recorded last year. Despite market headwinds, most of which remain out of our control, we're very excited about and remain committed to the long-term growth opportunities for the business, and we are committed to pursuing opportunities to maximize value for our shareholders. Now, with that, I'll turn the time back over to the operator. Sarah? Thank you. If you'd like to ask a question, please signal by pressing Star one on your telephone keypad. If you are using a speakerphone, please make sure your mute function is turned off to allow your signal to reach our equipment. Again, press star one to ask a question. We'll pause for just a moment to allow everyone an opportunity to signal for questions. We have no questions signaled at this time. Once again, a reminder, please press Star one to signal for a question. We will take our first question from Steven Martin with Slater. Hi, guys. Hey, Steve. I've asked you for the last two quarters why you weren't looking to save some costs and reduce some expenses. Now you announce you're gonna do it, but it's not gonna be effective till the end of 2023. I'm not quite sure I understand that. Sure. Second of all, I don't understand, with sales declining, your inventory went down a little, but why are you sitting on so much inventory, and why not generate some cash and buy back more shares? Buying back 90,000 shares is a joke. With respect to your first question on SG&A savings and the gross margin savings, we actually do have. Again, this is a, it's a comprehensive plan. It's a, I think it's a pretty striking plan. We've been working on this for, as Martin pointed out, for several months. There's a lot of complexity involved. We will have some savings rolling off the assembly line, Steve, in advance of, you know, kind of the timing that we told you. It's just that the bulk of it needs to go through cost of goods. There's an inventory turn, kind of issue there that we need to. You know, there's some complexity involved in, you know, Martin talks, for example, about, you know, having to reformulate a product. That's formulation, that's labels, that's approvals, then you get it into inventory, and it goes through. These are meaningful savings. I think they're quite impactful, and they're sustainable as well, and we feel really good about them. We do have a range of SG&A savings as well that will be coming through. Again, the lion's share of the opportunity is from driving out gross margin. We're just getting started here, right? This is an ongoing project. I feel very good about it. I think it's a strong effort. I want you to remember, we've already taken out some $26 million of savings over the past couple years. We're adding on top of that with our SG&A, and then the gross margin savings on top of that, I think are quite substantial. As it relates to the second question, John, you wanna take a stab at that? Yeah. Steven, yeah, we do have quite a bit of inventory on hand, and we're aware of that. Going into the beginning of last year, I mean, we were in a different place where we had, you know, higher expectations of growth before the war and everything else there. We, you know, we were buying inventory ahead of inflation, trying to, you know, make sure we had enough to support our growth. When that growth didn't come at the levels we expected, we already had commitments there. We're working through those commitments. We've canceled orders. You know, we're buying raw materials where needed, targeted buys, and we're continuing to just work down the inventory. I hope that answers your question. Well, the corollary to that is, with your stock at $8, why did you only buy back 90,000 shares? You know, we do have volume constraints, so, you know, we did buy with volume. We're also we have prioritized the investments that we talked about. There are some investments that are required in order to to drive out some of the costs from gross margin. You know, so we think those are actually very good, very strong priorities for us right now, given where we are. You know, it's a lot more, it's a lot harder and more expensive for us to reacquire new or acquire new customers than it is to try and keep our existing customers. That's really where our kind of our focus is right now, and then on driving out some of these costs, and we do have pretty sizable needs in terms of some of the things to upgrade equipment and upgrade facilities. That's just kind of coming online right now in terms of the investments. Well, speaking as one of your shareholders, I've heard those words before. I just assume you spend some money buying back some stock instead of sitting with $60 million on your balance sheet. Yep. Yep, we appreciate the sentiment. All right. I'll talk to you offline, next week. Thanks, Steve. At this time, that does conclude our question and answer session. I would like to turn the conference back over to Mr. Moorehead for closing remarks. Okay, thank you. Well, we'd like to thank everyone for listening to today's call, and we look forward to speaking with you when we report our fourth quarter and full year 2022 results in March of 2023. Thanks again for joining us. Take care. Ladies and gentlemen, this does conclude today's teleconference. You may disconnect your lines at this time. Thank you for your participation.